A prognostic nomogram for patients with HR+ mucinous breast carcinoma based on the SEER database and a Chinese cohort study
The established nomogram model provides an accurate prognostic prediction for HR+ MBC patients. NAC does not confer long-term survival benefits compared to AC. These findings provide a novel approach for prognostic prediction and clinical practice.
Authors
- Tiankuo Luan
- Pei Wang (ORCID: https://orcid.org/0000-0002-1650-3353)
- Jian Yue (ORCID: https://orcid.org/0009-0009-9868-0959)
- Huiying Fang (ORCID: https://orcid.org/0009-0001-5122-2485)
- Guosheng Ren (ORCID: https://orcid.org/0000-0002-6416-8967)
- Hongzhong Li (ORCID: https://orcid.org/0000-0002-8134-7174)
Institutions
- Chongqing University (CN)
- Third People's Hospital of Chengdu (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Cancer Hospital (CN)
- Gaozhou People's Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-08-23
- DOI
- https://doi.org/10.3389/fonc.2024.1444531
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Chongqing University
- Chongqing Medical University
- Natural Science Foundation of Chongqing